+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioCryst Pharmaceuticals Inc - logo

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.

From
Global Hereditary Angioedema Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Hereditary Angioedema Therapeutics Market 2023-2027

  • Report
  • July 2023
  • 156 Pages
  • Global
From
Herpes Simplex Virus Treatment Global Market Report 2024 - Product Thumbnail Image

Herpes Simplex Virus Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Hereditary Angioedema Therapeutics Global Market Report 2024 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Gout Therapeutics Global Market Report 2023 - Product Thumbnail Image

Gout Therapeutics Global Market Report 2023

  • Report
  • September 2023
  • 175 Pages
  • Global
From
From
Hereditary Angioedema - Pipeline Insight, 2022 - Product Thumbnail Image

Hereditary Angioedema - Pipeline Insight, 2022

  • Clinical Trials
  • August 2022
  • 90 Pages
  • Global
From
From
From
Loading Indicator